■Close to last year's low
Emerging markets fell sharply this week. As for the gain/fall rate for the same period, the Nikkei Average was -6.21%, while the Growth Market Index fell to -6.55% and the Growth Market 250 Index to -7.07%, falling above the Nikkei Average. Similar to the prime market, investor momentum deteriorated rapidly due to the effects of depreciation in US stocks due to the decline in semiconductor stocks and the tense situation in the Middle East. The main stocks, such as the growth market Core Index constituent stocks, generally had a sales advantage. Trading prices did not increase even during the decline, and since there were no investors aiming for a push, both the Growth Market Index and the Growth 250 Index had weak market developments where year-to-date lows were updated day by day. The weekend Growth 250 Index was temporarily sold until 629.46, which is close to last year's low (last year's low was 618.70).
As an individual stock, Combano ＜6574＞ was bought after announcing that all of the company's shares held by the largest shareholder, Mr. Tsuyoshi Aoki, had been transferred to NT, an asset management company where Mr. Aoki is the president. Also, Ecomot ＜3987＞ was purchased after the consolidated subsidiary GRIFFY (Tokyo) announced that it had developed a physical condition management solution “GenVital” for field workers in collaboration with Obayashi Group ＜1802＞. While Gix ＜9219＞ and GRCS ＜9250＞ were bought as financial accounting-related stocks, Jade Group (3558) and Value Holdings (9270) were sold. In addition, F Code (9211) was disgusted by dilution of stock value due to public offering and sales, etc., and was pushed for sale.
■Are there still clues and material difficulties, 2 IPOs
Emerging markets next week are likely to continue to be in a difficult situation with clues and material difficulties. Although CUC ＜9158＞ is preparing to announce financial results on 4/24 next week, financial results announcements for the main players, such as growth market Core index constituent stocks, are concentrated in mid-May. Note that CUC handles hospices and home-visit nursing for patients with intractable diseases, etc., and it seems difficult to become the core of shopping when considering themes.
It has reached an adjustment phase centered on US high-tech stocks, and semiconductor stocks, which also played a leading role in the prime market, are in a position of dominant sales. I would like to expect developments such as capital inflow into the growth market due to adjustments in the prime market, but sales prices in the growth market on the 18th of this week were 95.5 billion yen, a low level since 93.7 billion yen on 12/11 last year. As investors' sentiment worsened, push buying into falling main stocks was refrained, and it was limited to short-term trading aimed at an autonomous backlash against Anges ＜4563＞ and Canvas ＜4575＞, which had recently plummeted. Since there are no core stocks, the search did not expand. Next week, it seems that elimination law trading, such as short-term fund outflows and outflows to stocks with large price movements such as data section ＜3905＞ and laboro.ai ＜5586＞, will take center stage as well. I think the trend of the growth market index and the growth market 250 index in the year-to-date low range will continue for a while.
Furthermore, on the 24th, Regil ＜176A＞, which handles DX support through BPO etc. to power supply energy operators, etc., and Cojin Bio ＜177A＞, which handles contract manufacturing of cell processed products, etc. will be listed on the growth market on the 25th, respectively. Since there are many recent IPOs with poor performance after initial price formation, it is necessary to be careful about secondary investments.